Whether AI-driven or legacy applications, the endpoint is the decisive moment. As AI increases in use, having hardware and software that supports a high-performance experience for all staff will improve operational efficiency, patient outcomes, and revenue.
In December, the FDA published a draft guidance providing its recommendations on the use of digital health data acquisition in clinical investigations, signaling that regulatory acceptance of digital endpoints in support of drug approval may occur in the short-term.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.